SABRINA ROOFIAN: Open Payments
NPI 1063284784 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $154 |
| Janssen Biotech, Inc. | 6 | $139 |
| UCB, Inc. | 2 | $89 |
| Mallinckrodt Hospital Products Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| ViiV Healthcare Company | 1 | $19 |
| Invivyd Inc | 1 | $19 |
Products named: TREMFYA, Bimzelx, OTEZLA, ACTHAR, KRYSTEXXA, EVENITY, RINVOQ, Tymlos.
Industry payments across CA — which companies pay providers there.
